REGENERON PHARMACEUTICALS, INC. — Director's Dealing 2017

Aug 24, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REGENERON PHARMACEUTICALS INC (REGN)
CIK: 0000872589
Period of Report: 2017-08-22

Reporting Person: Landry Robert E (SVP Finance & CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-08-22	Common Stock	M	2000	$272.7	Acquired	9099	Direct
2017-08-22	Common Stock	F	1144	$476.1	Disposed	7955	Direct
2017-08-22	Common Stock	F	388	$476.1	Disposed	7567	Direct
2017-08-23	Common Stock	S	100	$474.14	Disposed	7467	Direct
2017-08-23	Common Stock	S	100	$475.53	Disposed	7367	Direct
2017-08-23	Common Stock	S	168	$477.1	Disposed	7199	Direct
2017-08-23	Common Stock	S	100	$478.61	Disposed	7099	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-08-22	Non-Qualified Stock Option (right to buy)	$272.7	M	2000	Disposed	2023-09-09	Common Stock (2000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	83	Indirect

Footnotes

F1: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F2: The stock option award vests in four equal annual installments, commencing one year after the date of grant.